Open House - Global Healthcare 2022: Aditxt | Edison Group

Open House - Global Healthcare 2022: Aditxt | Edison Group

Broadcast on: January 26, 2022
Duration: 10:47

Aditxt is a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring.

  • Co-Founder, Chairman, and CEO

    Amro Albanna, Co-Founder, Chairman, and CEO, Aditxt, Inc.

    Amro co-founded Aditxt in September 2017, focusing on advancing some of the most promising biotechnologies around the health of the immune system. The company has grown to become a global leader developing a new class of therapeutics designed to retrain the immune system to potentially address organ rejection, autoimmunity, and allergies. Prior to Aditxt, Amro founded multiple companies ranging from promising innovations including nano-sensors for detecting environmental gases, volatile compounds designed to interfere with mosquitoes’ smell neurons responsible for the protection against mosquito-borne diseases, and semiconductor sensors chips combining GPS & wireless technologies. Amro earned his Bachelor of Science Degree in Business Administration and Computer Information Systems from California State University, San Bernardino. He continued his informal education at California State Long Beach and Harvard Medical School (HMX online).

More from OETV

What's happening on OETV

No upcoming videos or events

We didn't find any upcoming videos or events in your selected timeframe. Change your timeframe or check back soon for more!

No upcoming videos or events

We didn't find any upcoming videos or events in your selected timeframe. Change your timeframe or check back soon for more!

X

We value your privacy

This website or its third party tools uses cookies, which are necessary for its functioning and required to achieve the purpose illustrated in our Privacy Policy. By clicking "Accept" or dismissing this notice, you agree to our website's use of cookies.